ERIS Lifesciences Ltd

Growth Ratio Summary

Growth Score : 6.00

The company demonstrates strong growth in revenue, operating profit, and assets, but earnings and net income growth are negative. This indicates operational improvements and asset expansion, but profitability is declining. The company needs to address the factors impacting earnings and net income to ensure sustainable growth across all key metrics.

Financial Ratio Summary

Financial Score : 8.00

The company exhibits strong financial performance in earnings per share and book value, but capital expenditures are a concern. High earnings per share and book value reflect enhanced profitability and shareholder value. The company is generating substantial profits for each share and maintaining a strong equity base. However, the company needs to manage its investments more efficiently.

Profitability Ratio Summary

Profitability Score : 10.00

The company demonstrates excellent profitability across all key metrics. High margins, returns on capital, equity, and assets indicate efficient and effective management. The company is generating substantial profits from its operations and investments. The company is maximizing shareholder wealth and maintaining a strong competitive position.

Efficiency Ratio Summary

Efficiency Score : 5.00

The company demonstrates mixed efficiency in utilizing its assets. Inventory management and sales are reasonably well-managed, but fixed asset and capital turnover are low. This suggests potential underutilization of fixed assets and capital. Improving the turnover of fixed assets and overall capital could significantly enhance the company's operational efficiency and profitability.

Coverage Ratio Summary

Coverage Score : 8.40

The company's ability to cover its interest expenses is very strong. However, its equity dividend coverage is just average. The company is easily meeting its debt obligations, but its dividend payouts are not as well-covered. The company is able to maintain its debt obligations comfortably.

Solvency Ratio Summary

Solvency Score : 10.00

The company's long-term financial stability is excellent. Low debt levels relative to equity and assets demonstrate a conservative approach to financing, reducing the risk of financial distress. A strong equity base provides a solid foundation for future growth and resilience against economic downturns. The company is well-positioned to manage its long-term obligations and capitalize on growth opportunities without excessive reliance on debt.

Liquidity Ratio Summary

Liquidity Score : 5.08

The company's ability to meet its short-term obligations is a mix of strengths and weaknesses. While the quick ratio and operating cash flow ratio are at acceptable levels, the current and cash ratios suggest potential difficulties in covering immediate liabilities. This indicates that while the company can convert some assets into cash, its overall liquidity position needs to be stronger to ensure smooth operations and financial flexibility.